Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor.
about
RNA Fluorescence with Light-Up AptamersManipulating the in vivo immune response by targeted gene knockdownEnhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles.Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles.Innovative delivery of siRNA to solid tumors by super carbonate apatite.RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applicationsSystemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.Stable RNA nanoparticles as potential new generation drugs for cancer therapy.Single molecule photobleaching (SMPB) technology for counting of RNA, DNA, protein and other molecules in nanoparticles and biological complexes by TIRF instrumentation.RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.Detection of human immunodeficiency virus RNAs in living cells using Spinach RNA aptamers.Advancement of the Emerging Field of RNA Nanotechnology.RNA Imaging with Dimeric Broccoli in Live Bacterial and Mammalian Cells.A Fluorescent Split Aptamer for Visualizing RNA-RNA Assembly In VivoMechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment.In-gel imaging of RNA processing using broccoli reveals optimal aptamer expression strategies.Fabrication of RNA 3D Nanoprisms for Loading and Protection of Small RNAs and Model Drugs.Physicochemically tunable polyfunctionalized RNA square architecture with fluorogenic and ribozymatic properties.RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.Light-Up RNA Aptamers and Their Cognate Fluorogens: From Their Development to Their Applications.Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.RNA-based micelles: A novel platform for chemotherapeutic drug loading and delivery.Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.RNA versatility, flexibility, and thermostability for practice in RNA nanotechnology and biomedical applications.Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor.Modular cell-internalizing aptamer nanostructure enables targeted delivery of large functional RNAs in cancer cell lines.Cotranscriptionally Folded RNA Nanostructures Pave the Way to Intracellular Nanofabrication
P2860
Q26742083-E1EA011D-78D1-48C1-85E7-EAA1DFBE4DDCQ28083494-315F1012-CC83-461C-92D1-7E4C34F0971AQ34115320-3B2B1D5E-4BDA-42F9-A664-C12A67A6E45BQ35027155-5B8020F9-082B-4D36-8D4D-C822A155F5D1Q35571504-000CD379-CD83-4853-80CB-A53340875494Q36020835-18D0021A-4D23-441E-A9C4-F5348076E4D2Q36185327-5AF532EE-F5C2-4517-8E09-38362CEFEC48Q36449335-9456FC8A-54DF-4BB4-A8BA-6D7E8C629025Q36490744-70B32544-4E3C-4114-9BE3-FE9A76D9F34CQ37640468-B831825F-5CBD-4C5F-A1DC-AA4F82BFB332Q38179751-EA9B8BCF-430D-44B1-BBE0-F59DCEA75804Q38728680-4E86F27C-8FB3-4C38-ABD3-743D5510AC5BQ38787586-AF5C65BE-76A8-478C-9E20-69C0BFD1D66AQ39065708-5948384D-BB68-4F45-B927-D0302BDFC327Q39904625-B006F43B-D2F5-4E8C-B7C1-0CCB51418C80Q40473649-A1738E1C-502A-4A1A-BE08-B3302FE675DEQ40564594-ADD8B00B-4B49-41DF-AD51-1F9FF9E6BEEFQ40987116-BA00E700-2D7F-47DE-BCA6-96BDF49A4829Q41600364-87EECB2A-2A84-4C0C-95A5-5972FA763AF7Q41885592-C3714582-8DD9-4C3B-B55E-4C4B74A2353EQ45863841-873ABE9D-1950-4817-9751-07CD2EC8EA28Q47199019-FD1D6450-4E7A-44EF-8917-484331EF39D8Q47204361-6C7EF63B-01E8-47D0-84D3-A2BE8B7031C1Q49529515-752B71DB-C5F8-422E-85E0-DA02CB0DF665Q49904261-607DC4B2-D6F6-483B-A707-FDEF5AB459A5Q49918947-9CC14279-E72D-460E-B157-7446140D99B5Q50144632-FDE4D82A-90F8-410E-9E23-8ECBF54A8D62Q52659947-DC7FD411-7C20-48E9-A148-B8778D953DDEQ55378823-4E5AC1A2-BA4A-42AF-B207-ED02FB6C93FCQ57156492-EAC963C2-AA60-436E-B746-75598681AED0
P2860
Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Programmable folding of fusion ...... of phi29 DNA packaging motor.
@en
Programmable folding of fusion ...... of phi29 DNA packaging motor.
@nl
type
label
Programmable folding of fusion ...... of phi29 DNA packaging motor.
@en
Programmable folding of fusion ...... of phi29 DNA packaging motor.
@nl
prefLabel
Programmable folding of fusion ...... of phi29 DNA packaging motor.
@en
Programmable folding of fusion ...... of phi29 DNA packaging motor.
@nl
P2093
P2860
P356
P1476
Programmable folding of fusion ...... of phi29 DNA packaging motor.
@en
P2093
Emil F Khisamutdinov
Peixuan Guo
P2860
P356
10.1093/NAR/GKT885
P407
P577
2013-09-30T00:00:00Z